Glistenings and PCO Evaluation for the Envista MX60

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Posterior capsule opacification (PCO) and glistenings development is among the primary reasons for sub-optimal visual capacity following cataract extraction surgery. Primary objective of this study is to evaluate the incidence of PCO and glistenings of the popular envista MX-60 intraocular lens (Bausch + Lomb) in a random sample of cataract patients who underwent phacoemulsification at least 1 year prior to their enrollment at the study

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313

NCT03184428

Posterior Capsule Opacification

COMPLETED

Influencing Factors of the Corneal Endothelial Cell Loss

NCT05265832

Cataract

COMPLETED NA

Quantification of Factors Influencing Endothelial Damage During Phacoemulsification

NCT05529485

Endothelial Cell Loss, Corneal Cataract Phacoemulsification

COMPLETED

Comparison of In-the-bag Stability Between Single-piece and Three-piece Intraocular Lens

NCT02609997

Cataract

COMPLETED NA

Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification

NCT01664689

Intraoperative Performance and Postoperative Outcomes Following Cataract Surgery

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

Participants who underwent phacoemulsification surgery and implantation of the Envista MX-60 IOL

Phacoemulsification

Intervention Type PROCEDURE

Phacoemulsification for cataract extraction with Envista MX-60 implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phacoemulsification

Phacoemulsification for cataract extraction with Envista MX-60 implantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Diagnosis of senile cataract with stage 3 nuclear opalescence according to the Lens Opacities Classification System III (LOCS-3) grading scale

Exclusion Criteria

Endothelial cell count less than 1900, glaucoma, IOP-lowering medications, former incisional surgery, former diagnosis of corneal disease, diabetes or autoimmune diseases

Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No